I believe elevating patient outcomes will require more connections across disciplines and the ecosystem. As a leader, I cultivate agile organizations that are empowered to collaborate and accelerate solutions. My background includes research and pharmacy experience across clinical, retail, specialty and health plan settings. In biopharma, I've learned from challenges and successes in general management and foundational roles across marketing, sales and account management leadership, pricing, global strategic marketing/market access. This includes: •Building and scaling businesses with P&Ls from launch to $1B+ across hematology/oncology, rare disease, inflammation, cardiovascular disease, and biosimilars•Navigating commercialization teams (biologics, small molecules, drug device combinations, cell and gene therapy) through clinical development strategy, cross functional launch readiness and go to market build•Leading and inspiring organizational change including business unit transformations from design to implementation, product turn arounds (from flat/declining to double digit growth), business development and biotech merger integration While I have a connection to Amgen, opinions are my own and do not represent Amgen’s position.